|
CTNNAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83808523956941E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-15 |
| Normal-vs-Stage2 |
9.374900E-04 |
| Normal-vs-Stage3 |
1.050370E-02 |
| Normal-vs-Stage4 |
4.598000E-01 |
| Stage1-vs-Stage2 |
5.920000E-01 |
| Stage1-vs-Stage3 |
1.982160E-01 |
| Stage1-vs-Stage4 |
1.523180E-01 |
| Stage2-vs-Stage3 |
5.200800E-01 |
| Stage2-vs-Stage4 |
2.058600E-01 |
| Stage3-vs-Stage4 |
4.625800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34225963677181E-13 |
| Normal-vs-AfricanAmerican |
4.5778003610053E-10 |
| Normal-vs-Asian |
3.045000E-01 |
| Caucasian-vs-AfricanAmerican |
8.253000E-01 |
| Caucasian-vs-Asian |
7.995000E-01 |
| AfricanAmerican-vs-Asian |
7.712400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62792002100787E-12 |
| Normal-vs-Female |
4.448900E-04 |
| Male-vs-Female |
4.660100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.6019999467315E-09 |
| Normal-vs-Extreme_Weight |
3.13082892944294E-14 |
| Normal-vs-Obese |
2.810100E-04 |
| Normal-vs-Extreme_Obese |
1.5707990463909E-11 |
| Normal_Weight-vs-Extreme_Weight |
4.617200E-01 |
| Normal_Weight-vs-Obese |
1.755820E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.043700E-03 |
| Extreme_Weight-vs-Obese |
3.643600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.179770E-02 |
| Obese-vs-Extreme_Obese |
2.586900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.468200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.49880133146507E-11 |
| Normal-vs-Age(61-80Yrs) |
1.66533453693773E-15 |
| Normal-vs-Age(81-100Yrs) |
4.19419999841963E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.729900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.651900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.224100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.502000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.200200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.705600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65867319878998E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
5.93789999999705E-05 |
| Normal-VS-Unclassified PRCC |
2.82720513666845E-11 |
| Type1 PRCC-VS-Type2 PRCC |
9.820100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
3.817800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.41249999994353E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
2.770800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.88178419700125E-16 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.86948242944618E-12 |
| Normal-vs-N1 |
3.899000E-01 |
| Normal-vs-N2 |
5.674800E-01 |
| N0-vs-N1 |
2.869700E-02 |
| N0-vs-N2 |
3.944600E-01 |
| N1-vs-N2 |
8.799800E-01 |
|
|
